Atorvastatin calcium NDC 75834-258

Product information

Brand name (proprietary)

Atorvastatin calcium

Generic name (nonproprietary)

atorvastatin calcium

Active ingredients

Atorvastatin — 80 mg/1

Dosage form

Tablet

Route

Oral

Labeler

NIVAGEN PHARMACEUTICALS, INC.

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 213853

Marketing start

Aug 26, 2020

Listing expires

Dec 31, 2026

Other FDA classes

Hydroxymethylglutaryl-CoA Reductase Inhibitors (Mechanism)

Identifiers

Product ID 75834-258_4580fe3c-b524-3a14-e063-6294a90a34d3SPL ID 4580fe3c-b524-3a14-e063-6294a90a34d3SPL set ID 7c58bf4a-4a92-4db8-89bc-4de1b5831efcRxCUI 259255, 617310, 617311, 617312UNII A0JWA85V8FUPC 0375834258027, 0375834257501, 0375834255903, 0375834256016

Pharmacologic class

HMG-CoA Reductase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N475834025801 followed by a unit qualifier and the quantity Copy

Package 75834-0258-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 213853

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.